Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer that represents 15–20% of breast tumors and is more prevalent in young pre-menopausal women. It is the subtype of breast cancers with the highest metastatic potential and recurrence at the first 5 years after di...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Molecular Biosciences |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.903065/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|